179 related articles for article (PubMed ID: 20513406)
1. The conserved L5 loop establishes the pre-powerstroke conformation of the Kinesin-5 motor, eg5.
Larson AG; Naber N; Cooke R; Pate E; Rice SE
Biophys J; 2010 Jun; 98(11):2619-27. PubMed ID: 20513406
[TBL] [Abstract][Full Text] [Related]
2. The loop 5 element structurally and kinetically coordinates dimers of the human kinesin-5, Eg5.
Waitzman JS; Larson AG; Cochran JC; Naber N; Cooke R; Jon Kull F; Pate E; Rice SE
Biophys J; 2011 Dec; 101(11):2760-9. PubMed ID: 22261065
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the interaction of the Eg5 Loop5 with the nucleotide site.
Harrington TD; Naber N; Larson AG; Cooke R; Rice SE; Pate E
J Theor Biol; 2011 Nov; 289():107-15. PubMed ID: 21872609
[TBL] [Abstract][Full Text] [Related]
4. An allosteric transition trapped in an intermediate state of a new kinesin-inhibitor complex.
Kaan HY; Ulaganathan V; Hackney DD; Kozielski F
Biochem J; 2009 Dec; 425(1):55-60. PubMed ID: 19793049
[TBL] [Abstract][Full Text] [Related]
5. Photocontrol of mitotic kinesin Eg5 facilitated by thiol-reactive photochromic molecules incorporated into the loop L5 functional loop.
Ishikawa K; Tamura Y; Maruta S
J Biochem; 2014 Mar; 155(3):195-206. PubMed ID: 24334276
[TBL] [Abstract][Full Text] [Related]
6. Identification of the protein binding region of S-trityl-L-cysteine, a new potent inhibitor of the mitotic kinesin Eg5.
Brier S; Lemaire D; Debonis S; Forest E; Kozielski F
Biochemistry; 2004 Oct; 43(41):13072-82. PubMed ID: 15476401
[TBL] [Abstract][Full Text] [Related]
7. STLC-resistant cell lines as tools to classify chemically divergent Eg5 targeting agents according to their mode of action and target specificity.
Indorato RL; DeBonis S; Kozielski F; Garcia-Saez I; Skoufias DA
Biochem Pharmacol; 2013 Nov; 86(10):1441-51. PubMed ID: 24041742
[TBL] [Abstract][Full Text] [Related]
8. Terpendole E and its derivative inhibit STLC- and GSK-1-resistant Eg5.
Tarui Y; Chinen T; Nagumo Y; Motoyama T; Hayashi T; Hirota H; Muroi M; Ishii Y; Kondo H; Osada H; Usui T
Chembiochem; 2014 May; 15(7):934-8. PubMed ID: 24648249
[TBL] [Abstract][Full Text] [Related]
9. Thermodynamic properties of the kinesin neck-region docking to the catalytic core.
Rice S; Cui Y; Sindelar C; Naber N; Matuska M; Vale R; Cooke R
Biophys J; 2003 Mar; 84(3):1844-54. PubMed ID: 12609886
[TBL] [Abstract][Full Text] [Related]
10. Kinesin-5 allosteric inhibitors uncouple the dynamics of nucleotide, microtubule, and neck-linker binding sites.
Scarabelli G; Grant BJ
Biophys J; 2014 Nov; 107(9):2204-13. PubMed ID: 25418105
[TBL] [Abstract][Full Text] [Related]
11. Drug resistance dependent on allostery: A P-loop rigor Eg5 mutant exhibits resistance to allosteric inhibition by STLC.
Indorato RL; DeBonis S; Garcia-Saez I; Skoufias DA
Front Oncol; 2022; 12():965455. PubMed ID: 36313676
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of the mitotic spindle kinesin Eg5 reveals a novel conformation of the neck-linker.
Turner J; Anderson R; Guo J; Beraud C; Fletterick R; Sakowicz R
J Biol Chem; 2001 Jul; 276(27):25496-502. PubMed ID: 11328809
[TBL] [Abstract][Full Text] [Related]
13. Molecular dissection of the inhibitor binding pocket of mitotic kinesin Eg5 reveals mutants that confer resistance to antimitotic agents.
Brier S; Lemaire D; DeBonis S; Forest E; Kozielski F
J Mol Biol; 2006 Jul; 360(2):360-76. PubMed ID: 16780877
[TBL] [Abstract][Full Text] [Related]
14. Loop L5 assumes three distinct orientations during the ATPase cycle of the mitotic kinesin Eg5: a transient and time-resolved fluorescence study.
Muretta JM; Behnke-Parks WM; Major J; Petersen KJ; Goulet A; Moores CA; Thomas DD; Rosenfeld SS
J Biol Chem; 2013 Nov; 288(48):34839-49. PubMed ID: 24145034
[TBL] [Abstract][Full Text] [Related]
15. ATPase mechanism of Eg5 in the absence of microtubules: insight into microtubule activation and allosteric inhibition by monastrol.
Cochran JC; Gilbert SP
Biochemistry; 2005 Dec; 44(50):16633-48. PubMed ID: 16342954
[TBL] [Abstract][Full Text] [Related]
16. "Snapshots" of ispinesib-induced conformational changes in the mitotic kinesin Eg5.
Kaan HY; Major J; Tkocz K; Kozielski F; Rosenfeld SS
J Biol Chem; 2013 Jun; 288(25):18588-98. PubMed ID: 23658017
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the human kinesin Eg5 that confer resistance to monastrol and S-trityl-L-cysteine in tumor derived cell lines.
Tcherniuk S; van Lis R; Kozielski F; Skoufias DA
Biochem Pharmacol; 2010 Mar; 79(6):864-72. PubMed ID: 19896928
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of new allosteric inhibition in Kinesin spindle protein Eg5.
Yokoyama H; Sawada J; Katoh S; Matsuno K; Ogo N; Ishikawa Y; Hashimoto H; Fujii S; Asai A
ACS Chem Biol; 2015 Apr; 10(4):1128-36. PubMed ID: 25622007
[TBL] [Abstract][Full Text] [Related]
19. Mapping the structural and dynamical features of kinesin motor domains.
Scarabelli G; Grant BJ
PLoS Comput Biol; 2013; 9(11):e1003329. PubMed ID: 24244137
[TBL] [Abstract][Full Text] [Related]
20. Two conformations in the human kinesin power stroke defined by X-ray crystallography and EPR spectroscopy.
Sindelar CV; Budny MJ; Rice S; Naber N; Fletterick R; Cooke R
Nat Struct Biol; 2002 Nov; 9(11):844-8. PubMed ID: 12368902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
